Abstract
Global and regional myocardial uptake was determined with technetium-99m tetrofosmin and a 4 hour exercise (370 MBq iv) and rest (740 MBq iv) protocol, in 24 patients with non-insulin dependent diabetes mellitus and in 22 control subjects. The purpose of this study was to evaluate impaired coronary microvascular function in diabetics by measurement of % uptake increase in myocardial counts. The parameter of % uptake increase (°MTU) was calculated as the ratio of exercise counts to rest myocardial counts with correction of myocardial uptake for dose administered and physical decay between the exercise study and the rest study. Global °MTU was significantly lower in the diabetics than in control subjects (14.4±5.4% vs. 21.7±8.5%, p<0.01). Regional °MTU in each of 4 left ventricular regions (anterior, septal, inferior, posterolateral) was significantly lower in the diabetic group than in the control group (p<0.01) respectively, but there were no significant differences between °MTU in the 4 left ventricular regions in the same group. °MTU was useful as a non-invasive means of evaluating impaired coronary microvascular function in diabetics.
Similar content being viewed by others
References
Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart.N Engl J Med 302: 384–388, 1980.
Sutherland CG, Fisher BM, Frier BM, Dargie HJ, Lindop GBM. Endomyocardial biopsy pathology in insulin-dependent patients with abnormal ventricular function.Histopathology 14: 593–602, 1988.
Fein FS, Sonnenblick EH. Diabetic cardiomyopathy.Prog Cardiovasc Dis 27: 255–270, 1985.
Zarich SW, Nesto RW. Diabetic cardiomyopathy.Am Heart J 118: 1000–1012, 1989.
Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material.J Pathol 166: 265–270, 1992.
Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.Circulation 91: 635–640, 1995.
Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and Achinduced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.Diabetes 42: 1017–1025, 1993.
Marcus M, Wright C, Doty D, Eastham C, Laughlin D, Krumm P, et al. Measurements of coronary velocity and reactive hyperemia in the coronary circulation of humans.Circ Res 49: 877–891, 1981.
Wilson RF, Laughlin DE, Ackel PH, Chilian WM, Holida MD, Hartley CJ, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man.Circulation 72: 82–92, 1985.
Doucett JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.Circulation 85: 1899–1911, 1992.
Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries.Am J Cadiol 71: 3D-9D, 1993.
White CW. Clinical applications of Doppler coronary flow reserve measurements.Am J Cardiol 71: 10D-16D, 1993.
Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM.Diabetes 47: 119–124, 1998.
Pikanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, et al. Coronary flow reserve is reduced in young men with IDDM.Diabetes 47: 248–254, 1998.
Davidson CJ, Fishman RF, Bonow RO. Cardiac catheterization.In Heart Disease, Braunwald E (ed.), 5th ed., Philadelphia, W.B. Saunders, Inc., pp. 199–200, 1997.
Opherk D, Mall G, Zebe H, Scwarz F, Weihe E, Manthey J, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.Circulation 69 (1): 1–7, 1984.
Lucarini AR, Picano E, Salvetti A. Coronary microvascular disease in hypertensives.Clin Exp Hypertens A14: 55–66, 1992.
Cannon RO 3d, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries.J Am Coll Cardiol 1: 1359–1373, 1983.
Legrand V, Hodgson JM, Bates ER, Aueron FM, Mancini GB, Smith JS, et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms.J Am Coll Cardiol 6: 1245–1253, 1985.
Kinoshita N, Sugihara H, Nakamura T, Ito K, Azuma A, Maeda T, et al. A calculation of an index of the coronary flow reserve using exercise and rest myocardial SPECT with technetium-99m tetrofosmin.KAKU IGAKU (Jpn J Nucl Med) 34: 45–48, 1997.
Hori A, Taki J, Nakajima K, Shimizu M, Tonami N. Evaluation of ischemic heart disease using the index of relative99mTc-tetrofosmin uptake increase at exercise.KAKU IGAKU (Jpn J Nucl Med) 34: 433–441, 1997.
Takahashi K, Takeishi Y, Fujiwara S, Atsumi H, Akutsu T, Komatani A, et al. Quantitative assessment of an increase of myocardial99mTc-MIBI accumulation during exercise —usefulness of response rate—.KAKU IGAKU (Jpn J Nucl Med) 33: 779–784, 1996.
Fujiwara S, Takeishi Y, Atsumi H, Chiba J, Takahashi K, Tomoike H. Quantitative assessment of myocardial99mTc-sestamibi uptake during exercise: usefulness of response rate for assessing severity of coronary artery disease.Jpn Circ J 62: 592–598, 1998.
Buell U, Kaiser HJ, Dupont F, Uebis R, Kleinhans E, Hanrath P. Methoxyisobutylisonitrile (MIBI) Tc 99m SPECT to establish a correlate to coronary flow reserve, the perfusion reserve, from global and regional myocardial uptake after exercise and rest.Eur J Nucl Med 16: 3–9, 1990.
Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise.Circulation 50: 1179–1189, 1974.
Durante W, Sunahara FA, Sen AK. Effect of diabetes on metabolic coronary dilatation in the rat.Cardiovasc Res 23: 40–45, 1989.
Downing SE, Lee JC, Weinstein EM. Coronary dilator actions of adenosine and CO2 in experimental diabetes.Am J Physiol 243: H252-H258, 1982.
Koltai MZ, Roesen P, Hadhazy P, Ballagi-Podany G, Koszeghy A, Pogatsa G. Effects of hypoxia and adrenergic stimulation induced alterations in PGI2 synthesis by diabetic coronary arteries.J Diabet Complications 2: 5–7, 1988.
Berne RM, Levy MN. Coronary circulation and cardiac metabolism.In Cardiovascular Physiology, Berne RM, Levy MN (eds.), 2nd ed., Saint Louis, The C.V. Mosby company, Inc., pp. 206–217, 1972.
Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.J Nucl Med 35: 664–671, 1994.
Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: uptake into isolated adult rat ventricular myocytes and subcellular localization.J Nucl Cardiol 2: 317–326, 1995.
Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria.J Nucl Cardiol 2: 327–333, 1995.
Scharmroth L. Electrophysiology and electropathology.In The Electrocardiology of Coronary Artery Disease, Scharmroth L (ed.), 1st ed., Oxford London Edinburgh Melbourne, Blackwell Scientific publications, pp. 11–24, 1977.
Mahta JL. Endothelium, coronary vasodilation, and organic nitrates.Am Heart J 129 (2): 382–391, 1995.
Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not byl-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.Circulation 97: 736–743, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsujimoto, G. Impaired coronary microvascular function in diabetics. Ann Nucl Med 14, 165–172 (2000). https://doi.org/10.1007/BF02987855
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02987855